Evidence map›Paper›PMID 30612336›Full record

ReviewMolecular neurobiology2019

Bilirubin and Ischemic Stroke: Rendering the Current Paradigm to Better Understand the Protective Effects of Bilirubin.

Mrugesh Thakkar, Jurian Edelenbos, Sylvain Doré

4 registry-linked trialsOpen access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06474507 narecruitingnot on this mapstarted 2024, after this paper: background citation

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease

TypeinterventionalSponsorTongji HospitalRan2024 to 2029Enrolled230ConditionsIschemic Cerebrovascular Disease, Acute Ischemic Stroke, Cerebral Small Vessel DiseasesArmsCalculus bovis sativus (CBS)
NCT06474520 narecruitingnot on this mapstarted 2024, after this paper: background citation

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease

TypeinterventionalSponsorTongji HospitalRan2024 to 2029Enrolled250ConditionsIdiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseArmsCalculus bovis sativus (CBS)
NCT06584045 narecruitingnot on this mapstarted 2024, after this paper: background citation

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis

TypeinterventionalSponsorTongji HospitalRan2024 to 2029Enrolled250ConditionsEncephalitis, Encephalitis, Viral, Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody, Autoimmune EncephalitisArmsCalculus bovis sativus (CBS)
NCT07080632 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Intracerebral Hemorrhage

TypeinterventionalSponsorTongji HospitalRan2025 to 2027Enrolled300ConditionsIntracerebral Hemorrhage, Brain HemorrhageArmsCalculus bovis sativus (CBS), Natural Calculus Bovis(NCB)
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Bilirubin metabolism and its application in disease prevention: mechanisms and research advances.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mrugesh ThakkarDepartment of Anesthesiology, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Jurian EdelenbosDepartment of Anesthesiology, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Sylvain DoréDepartment of Anesthesiology, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA. sdore@ufl.edu.ORCID http://orcid.org/0000-0003-3771-5109
University of Florida · US

Funding

Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in StrokR01AT007429 · NCCIH · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2012 to 2016
$2.2M
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic PatientsR21NS095166 · NINDS · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2016 to 2017
$426k
CO therapeutic role and potential mechanism in TBIR21NS103036 · NINDS · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2018 to 2019
$419k
National Center for Complementary and Alternative Medicine R01AT007429NCCIH NIH HHS R01 AT007429NINDS NIH HHS R21 NS095166NINDS NIH HHS R21NS095166NINDS NIH HHS R21 NS103036NINDS NIH HHS R21NS103036
6 · The paper itself

Abstract

Novel and innovative methods are critical in fostering new treatments and improving clinical outcomes in patients who suffer from ischemic stroke. Bilirubin has long been considered metabolic waste that can be harmful to the body; however, it is now becoming recognized as one of the body's most potent antioxidant, anti-inflammatory, and neuroprotective molecules. These properties facilitate bilirubin's anti-atherogenic effects to impede and prevent the formation of thrombi in ischemic stroke. These functions allow for protection from neuronal injury during an ischemic state and suggest that elevated bilirubin levels may be linked to a lower rate of morbidity and mortality. Therefore, here we discuss the pathophysiology of stroke and the molecular properties of bilirubin to better understand their beneficial relationship. We outline clinical studies looking at the relationship between serum bilirubin levels and ischemic stroke prevalence. At this time, few studies have rigorously looked at the relationship between bilirubin and ischemic stroke, whether it is positive or negative. Thus, rigorous research is needed to provide evidence supporting the current studies, expand on these studies, and facilitate their translation to bedside therapy for patients who suffer from ischemic stroke.

Indexed as

AnimalsBilirubinBiomarkersBrain IschemiaHumansNeuroprotective AgentsOxidative StressStrokeBilirubinBiomarkersNeuroprotective AgentsAntioxidantIschemiaOutcomesProtectionTreatment

Identifiers

PMID30612336
OpenAlexW2908414812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.